[Request] Soligenix (SNGX)

Soligenix (NASDAQ) continues to build excitement for its SGX301 candidate following strong Phase 3 data and commercialization plans. The company recently held an investor webcast to further explain the company’s plans for commercializing its ground-breaking SGX301 candidate for the treatment of cutaneous T-cell lymphoma.

A lot of good DD info here: Marketscreener.com

Miffed, this is going up 40% today premarket.